Navigation Links
Martek Announces Fourth Quarter and FY 2009 Financial Results
Date:12/16/2009

suit between Martek and Lonza, Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH (collectively "Lonza"). The appeals involve Lonza's U.S. sale and use of DHA in functional foods and dietary supplements and do not involve Martek's core infant formula patents. The Federal Circuit ruled in Martek's favor on all four of the patents in question. One of the patents has been remanded to the District Court of Wilmington, Delaware for further proceedings.
  • Multi-Year Sole-Source Infant Formula Supply Agreement -- Martek entered into a multi-year, sole-source infant formula supply agreement with leading global dairy company Fonterra Co-operative Group Limited ("Fonterra"). Under the Fonterra agreement, Martek will supply its life'sDHA(TM) and life'sARA(TM) for all infant formula products manufactured by Fonterra and sold in Malaysia, Indonesia and China. Fonterra will also be using Martek's life'sDHA(TM) in its milk-based Annum(TM) Materna products for pregnant and nursing mothers sold in Indonesia, Taiwan, Hong Kong, the Philippines, Malaysia, Vietnam, Singapore, Thailand and China.
  • Non-Infant Formula Product Launches -- New non-infant formula nutritional products with Martek's life'sDHA(TM) were recently launched including Nutrioli® - DHA Cooking Oil (Ragasa - Mexico), Natrel Omega-3 Milk 2% (Agropur - Canada), Yogurt and Sweet Milk Beverages (Yantang Loby - China), Sugarless Bliss(TM) Dark Chocolate and Cupcakes with DHA (Diat Foods - India), Vaalia® Drinkable Yogurt (Parmalat - Australia) and pregnancy and nursing products PreferaOB + DHA(TM) (Alaven Pharmaceuticals - United States) and up&up(TM) DHA (Target - United States).
  • New Scientific Data Published on DHA and ARA -- The benefits of DHA and ARA supplementation were recently discussed in the following publications:
    • The American Journal of Clinical Nutrition (December 2009) reported 12-year follow
      '/>"/>

    SOURCE Martek Biosciences Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. Martek Signs Sole-Source Supply Agreement with Fonterra
    2. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
    3. Martek Announces Addition to Its Board of Directors
    4. Martek to Present at Two Upcoming Investor Conferences
    5. Martek Announces Settlement of Patent Dispute with Capsugel France
    6. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
    7. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
    8. Martek to Announce Third Quarter 2009 Results
    9. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
    10. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
    11. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
    (Date:1/22/2015)... 22, 2015   GenoSpace , a precision medicine software company ... the broad use of genomic, imaging and other biomedical data ... Michelle Munson , CEO of Aspera, an IBM Company, ... - http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased ...
    (Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
    (Date:12/24/2014)... BOTHELL, Wash. , Dec. 24, 2014   BioLife Solutions ... manufacturer and marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" or ... Annual Meeting of Stockholders on May 4, 2015 (the "Annual ...
    Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
    ... will be one of the presenters at Digestive Disease ... in interventional gastroenterologyORANGEBURG, S.C., May 29 Zeus, Inc., ... it has been invited to present at Digestive Disease ... Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specialist Aubrey ...
    ... May 29 Dey L.P., a subsidiary of Mylan ... it has begun to market and distribute EMSAM(R) in ... monoamine oxidase inhibitor (MAOI), which was approved by the ... the treatment of major depressive disorder. EMSAM previously was ...
    ... have designed cells that can count and "remember" cellular events, ... activated in a specific order. , Such circuits, which mimic ... the number of times a cell divides, or to study ... biosensors that count exposures to different toxins. , The team ...
    Cached Biology Technology:Zeus to Present at Digestive Disease Week in Chicago 2Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder 2MIT, BU engineer cellular circuits that count events 2MIT, BU engineer cellular circuits that count events 3
    (Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
    (Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may be the ... Intelligence reports that the long anticipated floodgates for consumer ... demand for smart phones, tablets, and wearable mobile devices ... 2.5 billion users with nearly 4.8 billion biometric devices ...
    (Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
    Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
    ... University School of Medicine studies of Hispanic farmworkers in North ... had skin disease and that workers need more information about ... deadly diseases such as skin cancer. , Few studies have ... Wake Forest studies, 59 farmworkers from Nash and Johnston Counties ...
    ... most effective chemotherapy drugs against cancer is cisplatin because ... it also kills healthy tissue. Many scientists are creating ... treatments without side effects. One approach to analog development ... a Virginia Tech chemistry-biology research team that has been ...
    ... ensure complete tumor removal at breast cancer excision is ... used light waves in a newly explored region of ... and determine if the removed tissue margins were clear ... potential to eliminate the need for multiple surgeries and ...
    Cached Biology News:Skin disease common among Hispanic farmworkers in North Carolina, research shows 2Light activated anticancer drug targeted to DNA using cisplatin like sub-units 2Terahertz imaging may reduce breast cancer surgeries 2
    Human RXR beta/NR2B2 MAb (Clone H7341) Keywords: RXRbeta, RXRbeta, Retinoid X Receptor beta...
    Human SOST Affinity Purified Polyclonal Ab...
    BOND ELUT MATRIX-C18, 25 mg ...
    Prepared from plasminogen by activation with immobilized human uPA...
    Biology Products: